Compare CBUS & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CBUS | QTRX |
|---|---|---|
| Founded | 2010 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 142.7M | 160.0M |
| IPO Year | 2017 | 2017 |
| Metric | CBUS | QTRX |
|---|---|---|
| Price | $1.70 | $2.99 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $9.00 | $6.00 |
| AVG Volume (30 Days) | 150.5K | ★ 800.3K |
| Earning Date | 05-14-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.33 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $3,639,000.00 | ★ $37,632,000.00 |
| Revenue This Year | $112.72 | $25.49 |
| Revenue Next Year | $83.18 | $10.04 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 64.52 |
| 52 Week Low | $1.09 | $2.15 |
| 52 Week High | $4.19 | $8.77 |
| Indicator | CBUS | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 45.34 | 45.94 |
| Support Level | $1.55 | $2.27 |
| Resistance Level | $1.82 | $3.85 |
| Average True Range (ATR) | 0.14 | 0.27 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 33.14 | 47.09 |
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.